Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Rhinomed.
RELATED STOCKHEAD STORIES
News
Rise and Shine: What you need to know before the ASX opens
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Scale-up secret sauce: These are the ingredients for medtech growth
Health & Biotech
Health Kick Podcast: Increasing athletic performance and fighting sleep apnea with a simple nose clip
News
Weed Week: COVID-19 drags on sentiment as ASX-listed pot stocks go 0/33
Health & Biotech
The US legal pot market is massive and confusing: report
Health & Biotech
Air pollution is expected to get worse, but these small caps are trying to help and they just might benefit
Health & Biotech
Weed week: Canberra leads the way on cannabis, makes pot possession legal
Tech
Rhinomed shares shoot up 40pc as it tops up coffers, mulls new cannabis products
News
Lunchtime ASX small cap wrap: Who’s shocking everyone today?
Health & Biotech
Health: Immutep bounces off decade-long lows thanks to cash from GSK
News
Rise & Shine: What you need to know before the ASX opens
News
Weed Week: American pot could be worth $60 billion by 2025
News
Weekly small cap wrap: Who deserves a high five?
News
Weed Week: US looks at ways to help cannabis players get banking access
Health & Biotech
Rhinomed will explore links between poor sleep and suicide in new study
Health & Biotech
